Skip to main content
Premium Trial:

Request an Annual Quote

William Moffitt, Jay Lichter, Dereck Tatman, Murlai Prahalad, Pete De Spain, Istvan Merchenthaler, James Greenwood, Carl Feldbaum, Steve Lombardi

Premium

William Moffitt has been named president and chief executive officer of Nanosphere, a Northbrook, Ill.-based developer of a molecular diagnostics platform. Moffitt most recently served as president and CEO of I-Stat, a point-of-care diagnostics manufacturer. The company was purchased by Abbott Laboratories in 2003. Previous to his term at I-Stat, Moffitt held several executive positions at Deerfield, Ill.-based Baxter Healthcare.


Jay Lichter, who was executive vice president of business development at Sequenom, has left the company, an outside company spokesperson confirmed last week. Dereck Tatman and Murlai Prahalad, who serve as directors of business development at Sequenom, have assumed the duties held by Lichter. Also Pete De Spain, manager of corporate communications at Sequenom, has left the company, and is now manager of corporate communications at Anadys Pharmaceuticals, of San Diego.


Istvan Merchenthaler has been appointed chief medical officer at Phylogeny, the company said last week. Merchenthaler will oversee functional genomics studies for Phylogeny’s pharmaceutical and biotech clients, with an emphasis on understanding gene expression patterns in the central nervous system, the company said. Prior to joining Phylogeny, Merchenthaler was employed by Wyeth Research, where he served as a distinguished research scientist and director of functional morphology for the company’s Women’s Health Research Institute for 10 years.


Congressman James Greenwood (R-Pa.) was named the next president of the Biotechnology Industry Organization last week. Greenwood has represented the Eighth District of Pennsylvania in the US House of Representatives since 1993. He previously served in the Pennsylvania House and Senate, and since 2001, he has served as chairman of the Energy and Commerce Subcommittee on Oversight and Investigations. He will be replacing Carl Feldbaum, who has headed BIO since its establishment in July 1993.


Steve Lombardi has been named as a non-executive director of Paris-based molecular diagnostics firm IntegraGen. Lombardi is currently senior vice president of corporate development at Affymetrix.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.